(Q44132349)

30 November 2017

Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study (English)

1 reference

30 November 2017

L Voruganti

1

1 reference

30 November 2017

L Cortese

2

1 reference

30 November 2017

L Owyeumi

3

1 reference

30 November 2017

V Kotteda

4

1 reference

30 November 2017

Z Cernovsky

5

1 reference

30 November 2017

S Zirul

6

1 reference

30 November 2017

A Awad

7

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

30 November 2017

Schizophrenia Research

1 reference

30 November 2017

57

1 reference

30 November 2017

201-208

1 reference

30 November 2017

2-3

1 reference

Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900309-7

7 January 2021

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900309-7

7 January 2021

Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900309-7

7 January 2021

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900309-7

7 January 2021

The new atypical antipsychotics: a review of pharmacoeconomic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900309-7

7 January 2021

The new antipsychotics--some pharmacological aspects of their problems and potential

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900309-7

7 January 2021

From clinical trials to real-world practice: use of atypical antipsychotic medication nationally in the Department of Veterans Affairs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900309-7

7 January 2021

Tolerability of atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900309-7

7 January 2021

Should the treatment of schizophrenia include old antipsychotic drugs?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900309-7

7 January 2021

Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900309-7

7 January 2021

10.1016/S0920-9964(01)00309-7

Identifiers

DOI

1 reference

30 November 2017

1 reference